Quality of Life in Patients With Systemic Lupus Erythematosus Ramathibodi Hospital

Thanuchporn   Kafaksom; Nichapha Dechapaphapitak; Thanitta   Suangtamai; Pintip Ngamjanyaporn; Dhanesh Pitidhammabhorn; Nopparat Ruchakorn

doi:10.33165/rmj.2021.44.3.245850

Authors

Thanuchporn Kafaksom Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Nichapha Dechapaphapitak Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Thanitta Suangtamai Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Pintip Ngamjanyaporn Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Dhanesh Pitidhammabhorn Chakri Naruebodindran Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
Nopparat Ruchakorn Department of Medicine, Faculty of Medicine, Srinakharinwirot University, Nakorn Nayok, Thailand

DOI:

https://doi.org/10.33165/rmj.2021.44.3.245850

Keywords:

Systemic lupus erythematosus, Quality of life, Factors

Abstract

Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease. It is a chronic disease and exhibits symptoms in many organs and patients will be offered a variety of immunosuppressants, which may cause many side effects and worsen the quality of life.

Objective: To study the quality of life in SLE patients receiving treatment in Ramathibodi Hospital.

Methods: A cross-sectional study of all SLE patients were collected during February 2017 to February 2018, by using questionnaires to measure the quality of life.

Results: Total of 510 SLE patients, 96.7% were female. The mean (SD) age was 40.9 (13.0) years, and the disease duration was 10.5 (8.2) years. Most of them got a bachelor’s degree or higher (54.1%). Universal coverage scheme was the most treatment welfare of the patients. Despite the disease limitation for pregnancy, 7.2% of the SLE patients had 3 children while only 17.0% had miscarriages while pregnant. The general quality of life (SF-36) was in a good level, and disease-specific quality of life (SLEQoL) was at a moderate level. The older patients and a longer disease duration were inversely related to quality of life including physical health, overall health.

Conclusions: SLE patients who received the treatment at Ramathibodi Hospital had a relatively good quality of life. Factors related to quality of life were age and duration of the disease.

References

Tsang-A-Sjoe MWP, Bultink IEM, Heslinga M, van Tuyl LH, van Vollenhoven RF, Voskuyl AE. The relationship between remission and health-related quality of life in a cohort of SLE patients. Rheumatology (Oxford). 2019;58(4):628-635. doi:10.1093/rheumatology/key349

Stroie AM, Penescu MN, Petre N, Beldea G. Particularities of the evolution and therapeutic response in men with systemic lupus erythematosus and lupus nephritis. Internal Medicine. 2019;16(6):7-17. doi:10.2478/inmed-2019-0089

Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308-318. doi:10.1191/0961203306lu2305xx

Washio M, Kiyohara C, Ohta A. Epidemiology of Systemic Lupus Erythematosus. In: Lionaki S, ed. Lupus: New Advances and Challenges. IntechOpen; 2019:7-24. doi:10.5772/intechopen.84146

Mohamed A, Chen Y, Wu H, Liao J, Cheng B, Lu Q. Therapeutic advances in the treatment of SLE. Int Immunopharmacol. 2019;72:218-223. doi:10.1016/j.intimp.2019.03.010

Sokolova CR, Gamboa Cárdenas RV, Medina M, et al. SAT0581 Poor health-related quality of life (HRQoL) and fatigue are associated with a higher work productivity impairment in systemic lupus erythematosus (SLE) patients. Annals of the Rheumatic Diseases. 2019;78:1383. doi:10.1136/annrheumdis-2019-eular.6564

Leurmarnkul W, Meetam P. Properties testing of the retranslated SF-36 (Thai Version). Thai J Pharm Sci. 2005;29(1-2):69-88. Accessed May 5, 2021. http://www.thaiscience.info/journals/Article/TJPS/10471193.pdf

Kasitanon N, Wangkaew S, Puntana S, et al. The reliability, validity and responsiveness of the Thai version of systemic lupus erythematosus quality of life (SLEQOL-TH) instrument. Lupus. 2013;22(3):289-296. doi:10.1177/0961203312474702

Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144-150. doi:10.1097/BOR.0000000000000480

Davis-Porada J, Kim MY, Guerra MM, et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther. 2020;22(1):52. doi:10.1186/s13075-020-2139-9

Rivest C, Lew RA, Welsing PM, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol. 2000;27(3):680-684.

Chaigne B, Chizzolini C, Perneger T, et al. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS). BMC Immunol. 2017;18(1):17. doi:10.1186/s12865-017-0200-5

Wandner LD, Scipio CD, Hirsh AT, Torres CA, Robinson ME. The perception of pain in others: how gender, race, and age influence pain expectations. J Pain. 2012;13(3):220-227. doi:10.1016/j.jpain.2011.10.014

Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med. 2017;32(3):429-438. doi:10.3904/kjim.2016.234